Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05472454
Other study ID # 19288-001
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 7, 2022
Est. completion date May 1, 2023

Study information

Verified date November 2023
Source Washington State University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The proposed project explores the acceptability and health benefits of ready-to-eat (RTE) meals based on the Dietary Approaches to Stop Hypertension (DASH) eating plan. The researchers have developed 14 recipes following the DASH eating plan, which is recommended for the prevention of cardiovascular disease (CVD). The prepackaged meals will be processed using Washington State University (WSU) microwave technologies to ensure food safety. In this pilot study, a sample of 30 participants will be recruited by to study the impact of the DASH meals on blood pressure. All meals will be provided to participants, who will consume the meals daily over a period of 4 weeks. Daily and weekly monitoring of participants (blood pressure and weight) will allow us to gain a scientific understanding on the preventive power of healthy diets in lowering blood pressure and reducing CVD risk.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date May 1, 2023
Est. primary completion date May 1, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Male or female - 18 years old or older - BMI 18.5-40.0 kg/m2 - Daily access to working internet, microwave, refrigerator, and freezer - English fluency Exclusion Criteria: - Regular use of drugs that affect BP, including weight loss medications - Diagnosed hypertension OR systolic BP >130 and/or diastolic BP >80 - Diagnosis of any hypotensive disorders OR systolic BP <100 and/or diastolic BP<65 - Dietary restrictions, including allergy/intolerances - Presence or history of diabetes - Previous cardiac event, congestive heart failure, or angina - Weight loss or gain>15lb in previous 3 months - Following a diet to increase or decrease body weight - Cancer diagnosis or treatment in past 2 years - =14 alcoholic drinks/week for men; = 7 alcoholic drinks/week for women - Use of nicotine, marijuana, or illicit drugs - Pregnancy, planned pregnancy, or breastfeeding - Inability to comprehend the nature of the study or instructions - No access to the internet - Planning to leave the Spokane area during the study - Not fluent in the English language

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Ready-to-eat meals
Participant group to consume ready-to-eat meals in accordance with the DASH diet for a period of 4 weeks.

Locations

Country Name City State
United States Washington State University Spokane Washington

Sponsors (1)

Lead Sponsor Collaborator
Washington State University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Blood pressure To determine dietary patterns on blood pressure using an omron blood pressure monitor. through study completion, measured weekly for 5 weeks
Secondary Body weight (kg) To determine dietary patterns on body weight (kg) using a Angel USA 400 Pound Physician Digital Scale. through study completion, measured weekly for 5 weeks
See also
  Status Clinical Trial Phase
Terminated NCT04591808 - Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia Phase 3
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Completed NCT05491642 - A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses Phase 1
Completed NCT03093532 - A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT05529147 - The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
Recruiting NCT06363097 - Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
Recruiting NCT05976230 - Special Drug Use Surveillance of Entresto Tablets (Hypertension)
Completed NCT06008015 - A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers Phase 1
Completed NCT05387174 - Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period N/A
Completed NCT04082585 - Total Health Improvement Program Research Project
Recruiting NCT05121337 - Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension N/A
Withdrawn NCT04922424 - Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men Phase 1
Active, not recruiting NCT05062161 - Sleep Duration and Blood Pressure During Sleep N/A
Not yet recruiting NCT05038774 - Educational Intervention for Hypertension Management N/A
Completed NCT05087290 - LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
Completed NCT05621694 - Exploring Oxytocin Response to Meditative Movement N/A
Completed NCT05688917 - Green Coffee Effect on Metabolic Syndrome N/A
Recruiting NCT05575453 - OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure N/A